entity

CNS

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about CNS: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

11Connections

13Hypotheses

6Analyses

0Outgoing

11Incoming

2Experiments

13Debates

No AI portrait yet

Wiki Pages (21)

Knowledge base pages for this entity

Canonical Page

Outgoing (0)

Target	Relation	Type	Str
No outgoing edges

Incoming (11)

Source	Relation	Type	Str
cell-types-nodes-ranvier-neurod	describes	wiki_page	1.00
39009412	penetrate	paper	0.90
BI-hTFR1	mediates	protein	0.90
29563219	is the primary lipid carrier within	paper	0.90
38898538	is expressed outside	paper	0.90
BDNF	expressed_in	protein	0.87
JEV	infects	virus	0.80
MICROGLIA	expressed_in	cell_type	0.76
MS	regulates	disease	0.72
therapeutic agents	associated_with	drug	0.70
DAM	expressed_in	cell_type	0.68

Targeting Hypotheses (13)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Focused Ultrasound with Microbubble Contrast Agents for Anti	0.893	neurodegeneration	Blood-brain barrier antibody transport m
pH-Sensitive Bispecific Antibody Targeting Transferrin Recep	0.800	neurodegeneration	Blood-brain barrier antibody transport m
LRP1-Mediated Transcytosis for CNS Antibody Delivery	0.680	neurodegeneration	Blood-brain barrier antibody transport m
AQP4 Dysregulation Promotes Neuroinflammation Through Impair	0.680	neurodegeneration	What are the specific molecular mechanis
Leaky Gut LPS Translocation Activates Systemic TLR4/MyD88 Si	0.670	neurodegeneration	How does gut microbiome dysbiosis contri

Glial-Autophagy-Senescence Coupling Defines CNS Therapeutic	0.614	molecular biology	What is the optimal therapeutic window t
Brain-Ester Prodrug Strategy for CNS-Selective HDAC6 Inhibit	0.570	pharmacology	How can CNS-selective HDAC/DNMT inhibito
MFSD2A-Targeted Lysophosphatidylcholine-SPM Conjugates as CN	0.552	neuropharmacology	What determines blood-brain barrier pene
Pharmacogenomic CNS Drug Optimization Platform	0.524	neurodegeneration	How do neurodegeneration gene expression
CCR2+ Monocyte Depletion as Restoration of CNS Immune Privil	0.490	immunomics	Systemic immune profiling in neurodegene
C1q-Alectinib Complexation Enhances CNS Penetration via Micr	0.415	molecular biology	Does Alectinib truly bind C1q directly w
hs-CRP-Driven CCR2+ Monocyte Recruitment Disrupts CNS Immune	0.000	immunomics	Systemic immune profiling in neurodegene
CCR2+ Monocyte Reprogramming via IL-10 Enhancement for CNS I	0.000	immunomics	Systemic immune profiling in neurodegene

Mentioning Analyses (6)

Scientific analyses that reference this entity

Systemic immune profiling in neurodegeneration: peripheral inflammation as drive

immunomics | 2026-04-16 | 10 hypotheses Top: 0.540

How do synthetic EVs achieve brain-specific targeting while avoiding reticuloend

drug delivery | 2026-04-15 | 0 hypotheses

What determines blood-brain barrier penetration kinetics for specialized pro-res

neuropharmacology | 2026-04-13 | 2 hypotheses Top: 0.552

What are the specific molecular mechanisms by which AQP4 dysfunction contributes

neurodegeneration | 2026-04-07 | 7 hypotheses Top: 0.690

Systemic immune profiling and peripheral immune contributions to neurodegenerati

neurodegeneration | 2026-04-04 | 0 hypotheses

Experiments (2)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
Epigenetic clocks association with brain aging patterns in older women	exploratory	cognitive impairment and demen	0.900	0.00	human patients	proposed	N/A
Autophagy receptor identification for stress granule elimination	exploratory	neurodegenerative diseases	0.900	0.00	cultured cells under arsenite	proposed	N/A

Related Papers (5)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810]	["Chen Kai", "Li Fuyao", "Zhang Shuwen",	Journal of neuroinflammation	2025
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810]	["Chen Kai", "Li Fuyao", "Zhang Shuwen",	Journal of neuroinflammation	2025
Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554]	Marogianni C, Sokratous M, Dardiotis E,	International journal of molec	2020
Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554]	Marogianni C, Sokratous M, Dardiotis E,	International journal of molec	2020
Multiple Sclerosis Pathology. [PMID:29358320]	Lassmann H	Cold Spring Harbor perspective	2018

Debates (13)

Multi-agent debates referencing this entity

Hypothesis debate: SASP Modulation Rather Than Cell Elimination

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Should metabolic reprogramming via SIRT1/NAD+/PGC-1alpha axis be prioritized to

closed · Rounds: 4 · Score: 0.81 · 2026-04-23

The abstract states that AQP4 'is part of the pathogenesis' of CNS disorders and

closed · Rounds: 4 · Score: 0.76 · 2026-04-21

How does chronic peripheral inflammation interact with CNS neuroimmune pathways

closed · Rounds: 4 · Score: 0.50 · 2026-04-18

Investigate the therapeutic potential of clearing senescent cells (senolytics) t

closed · Rounds: 4 · Score: 0.75 · 2026-04-16

All participants identified brain delivery as a critical barrier, but no mechani

closed · Rounds: 4 · Score: 0.50 · 2026-04-16

The debate highlighted BBB penetration as a major hurdle for SPM therapeutics bu

closed · Rounds: 4 · Score: 0.66 · 2026-04-13

How do peripheral immune system alterations influence CNS pathology and neurodeg

closed · Rounds: 4 · Score: 0.76 · 2026-04-12

Related Research

Hypotheses and analyses mentioning CNS in their description or question text

Glial-Autophagy-Senescence Coupling Defines CNS Therapeutic Windows

Score: 0.614 · molecular biology · 2026-04-21

## Mechanistic Overview Glial-Autophagy-Senescence Coupling Defines CNS Therapeutic Windows starts from the claim that m

Brain-Ester Prodrug Strategy for CNS-Selective HDAC6 Inhibition

Score: 0.570 · pharmacology · 2026-04-21

## Mechanistic Overview Brain-Ester Prodrug Strategy for CNS-Selective HDAC6 Inhibition starts from the claim that modul

MFSD2A-Targeted Lysophosphatidylcholine-SPM Conjugates as CNS-Penetrant Pro-Reso

Score: 0.552 · neuropharmacology · 2026-04-13

## Mechanistic Overview MFSD2A-Targeted Lysophosphatidylcholine-SPM Conjugates as CNS-Penetrant Pro-Resolving Prodrugs s

Pharmacogenomic CNS Drug Optimization Platform

Score: 0.524 · neurodegeneration · 2026-04-12

## **Molecular Mechanism and Rationale** The pharmacogenomic CNS drug optimization platform leverages fundamental diffe

CCR2+ Monocyte Depletion as Restoration of CNS Immune Privilege

Score: 0.490 · immunomics · 2026-04-25

CCR2+ Monocyte Depletion as Restoration of CNS Immune Privilege

C1q-Alectinib Complexation Enhances CNS Penetration via Microglial C1qR-Mediated

Score: 0.415 · molecular biology · 2026-04-21

## Mechanistic Overview C1q-Alectinib Complexation Enhances CNS Penetration via Microglial C1qR-Mediated Uptake and Redi

hs-CRP-Driven CCR2+ Monocyte Recruitment Disrupts CNS Immune Privilege via IL-1β

Score: 0.000 · immunomics · 2026-04-26

Circulating hs-CRP directly triggers CCR2+ monocyte recruitment to the CNS by enhancing CCL2 expression in brain endothe

CCR2+ Monocyte Reprogramming via IL-10 Enhancement for CNS Immune Privilege Rest

Score: 0.000 · immunomics · 2026-04-26

Rather than depleting CCR2+ monocytes, this hypothesis proposes reprogramming their phenotype through targeted IL-10 pat

CNS

Understanding Entity Pages

Wiki Pages (21)

Gut-First vs Brain-First Alpha-Synuclein Propagation in Parkinson's Disease

Microglia-Targeted Nanoparticles for CNS Delivery

BBB-Transcytosis Shuttle for Episodic CNS PROTAC Delivery

CNS Drug Delivery Methods

Engineered Exosomes for Intranasal CNS Delivery

KCNS3 (Kv9.3)

BBB Transcytosis Shuttle for Episodic CNS PROTAC Delivery

CNS Vasculitis

CNS Lymphatic and Meningeal Immunity in 4R-Tauopathies

RMT-TfR1 Bispecific Antibody Shuttle for CNS Delivery

Exosome-Based CNS Delivery for Gene Therapy

Akkermansia muciniphila in CNS Disorders

Lipid Nanoparticle Delivery for CNS Gene Therapy

AAV Capsid Engineering for CNS-Targeted Neurodegeneration Therapy

Oligodendrocytes in CNS Myelination

KCNS2 Gene

CNS-Selective NLRP3 Inflammasome Inhibitor

Lipid Nanoparticle (LNP) CNS Delivery

AAV Serotype CNS Delivery Optimization Therapy

KCNS1 Gene

B-Lymphocytes (CNS)

Outgoing (0)

Incoming (11)

Targeting Hypotheses (13)

Mentioning Analyses (6)

Systemic immune profiling in neurodegeneration: peripheral inflammation as drive

How do synthetic EVs achieve brain-specific targeting while avoiding reticuloend

What determines blood-brain barrier penetration kinetics for specialized pro-res

What are the specific molecular mechanisms by which AQP4 dysfunction contributes

Systemic immune profiling and peripheral immune contributions to neurodegenerati

Senescent cell clearance as neurodegeneration therapy

Experiments (2)

Related Papers (5)

Debates (13)

Hypothesis debate: SASP Modulation Rather Than Cell Elimination

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

Should metabolic reprogramming via SIRT1/NAD+/PGC-1alpha axis be prioritized to

The abstract states that AQP4 'is part of the pathogenesis' of CNS disorders and

How does chronic peripheral inflammation interact with CNS neuroimmune pathways

Investigate the therapeutic potential of clearing senescent cells (senolytics) t

All participants identified brain delivery as a critical barrier, but no mechani

The debate highlighted BBB penetration as a major hurdle for SPM therapeutics bu

How do peripheral immune system alterations influence CNS pathology and neurodeg

Related Research

Glial-Autophagy-Senescence Coupling Defines CNS Therapeutic Windows

Brain-Ester Prodrug Strategy for CNS-Selective HDAC6 Inhibition

MFSD2A-Targeted Lysophosphatidylcholine-SPM Conjugates as CNS-Penetrant Pro-Reso

Pharmacogenomic CNS Drug Optimization Platform

CCR2+ Monocyte Depletion as Restoration of CNS Immune Privilege

C1q-Alectinib Complexation Enhances CNS Penetration via Microglial C1qR-Mediated

hs-CRP-Driven CCR2+ Monocyte Recruitment Disrupts CNS Immune Privilege via IL-1β

CCR2+ Monocyte Reprogramming via IL-10 Enhancement for CNS Immune Privilege Rest